![Artwork for Signals From [Space]](https://substackcdn.com/image/fetch/$s_!IXc-!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9f7142a0-6602-495d-ab65-0e4c98cc67d4_450x450.png)
The business, science, and policy of kidney health. Read by 20,000+ clinicians, operators, advocates, and policy makers across 65+ countries.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 179 | Founded | 3 years ago | Last Issue | 7 days ago |
| Active | |||||
![Artwork for Signals From [Space]](https://substackcdn.com/image/fetch/$s_!IXc-!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9f7142a0-6602-495d-ab65-0e4c98cc67d4_450x450.png)
Dear Kidneyverse,
Three years ago, I started writing this newsletter because I couldn’t find one that covered kidney health the way I thought it deserved to be covered. To be honest, it was mostly a scratch pad to share my thoughts as a fi...
So much for a slowdown in July. Signals is your monthly digest of the news, research, and people shaping kidney health. Subscribe below to get it in your inbox. This month also marks three years of writing Signals, now read regularly by 20K...
We’re now in the back half of 2026, and the kidney value-based care market is sending mixed signals. A new actuarial analysis suggests the Kidney Care Choices model may be performing better than its early evaluations showed, even as CMS red...
Nephrology has long relied on a handful of broadly acting therapies for chronic kidney disease. But there are more than 150 distinct rare and genetic kidney diseases, most with few or no dedicated treatments of their own, until now. We’re s...
Kidney transplant is one of medicine’s great success stories. For many patients, it offers years of life, freedom from dialysis, and the chance to return to school, work, family, and plans they may not have thought possible.
But the work d...
Subscribers, engagement, traffic and sponsorship for Signals From [Space].
| Subscribers | Engagement | 71 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Founder, writer, and investor in kidney and CKM health. Author of the leading newsletter on kidney innovation. Building the first dedicated venture fund in the space. Former medtech CEO, US Navy, and TMT trader. Learn more at trfitzpatrick.com
Janis Naeve is a scientist, investor, and healthcare strategist with experience across biotech, venture capital, and care delivery. She focuses on how data, policy, and clinical practice intersect to improve outcomes in chronic disease.
Director of Data Science and NURTuRE at Kidney Research UK
You can find recent issues that have been published by Signals From [Space] on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Signals From [Space], simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Signals From [Space] as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Signals From [Space] using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Signals From [Space]. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.